Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Frye

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Reviews. Drug Discovery|April 13, 2012
Stephen Frye. Interview by Asher MullardStephen Frye
Molecular Pharmacology|November 15, 2012
Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small moleculesPilar Blancafort, Jian Jin, Stephen Frye
RSC Medicinal Chemistry|December 23, 2022
The future of chemical probes is diversitySusanne Müller, Stephen Frye, Jonathan Baell
Nature Reviews. Drug Discovery|June 2, 2011
US academic drug discoveryStephen Frye, Marina Crosby, Teresa Edwards, et al.
Nature Reviews. Drug Discovery|November 1, 2013
Bringing together the academic drug discovery communityBarbara S Slusher, P Jeffrey Conn, Stephen Frye, et al.
Journal of Medicinal Chemistry|May 5, 2022
Publication Criteria and Requirements for Studies on Protein Kinase Inhibitors─What Is Expected?Stefan Laufer, Jürgen Bajorath, Matthias Gehringer, et al.
Journal of the American Chemical Society|March 25, 2011
Biophysical probes reveal a "compromise" nature of the methyl-lysine binding pocket in L3MBTL1Cen Gao, J Martin Herold, Dmitri Kireev, et al.
Plos Pathogens|September 14, 2018
Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latencySharon E Hopcraft, Samantha G Pattenden, Lindsey I James, et al.
Biochemical Pharmacology|February 11, 2021
MerTK activity is not necessary for the proliferation of glioblastoma stem cellsMonira Hoque, Siu Wai Wong, Ariadna Recasens, et al.
Oncotarget|March 13, 2015
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemiaAlisa B Lee-Sherick, Weihe Zhang, Kelly K Menachof, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Reviews. Drug Discovery|April 13, 2012
Stephen Frye. Interview by Asher MullardStephen Frye
Molecular Pharmacology|November 15, 2012
Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small moleculesPilar Blancafort, Jian Jin, Stephen Frye
RSC Medicinal Chemistry|December 23, 2022
The future of chemical probes is diversitySusanne Müller, Stephen Frye, Jonathan Baell
Nature Reviews. Drug Discovery|June 2, 2011
US academic drug discoveryStephen Frye, Marina Crosby, Teresa Edwards, et al.
Nature Reviews. Drug Discovery|November 1, 2013
Bringing together the academic drug discovery communityBarbara S Slusher, P Jeffrey Conn, Stephen Frye, et al.
Journal of Medicinal Chemistry|May 5, 2022
Publication Criteria and Requirements for Studies on Protein Kinase Inhibitors─What Is Expected?Stefan Laufer, Jürgen Bajorath, Matthias Gehringer, et al.
Journal of the American Chemical Society|March 25, 2011
Biophysical probes reveal a "compromise" nature of the methyl-lysine binding pocket in L3MBTL1Cen Gao, J Martin Herold, Dmitri Kireev, et al.
Plos Pathogens|September 14, 2018
Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latencySharon E Hopcraft, Samantha G Pattenden, Lindsey I James, et al.
Biochemical Pharmacology|February 11, 2021
MerTK activity is not necessary for the proliferation of glioblastoma stem cellsMonira Hoque, Siu Wai Wong, Ariadna Recasens, et al.
Oncotarget|March 13, 2015
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemiaAlisa B Lee-Sherick, Weihe Zhang, Kelly K Menachof, et al.
Pageof 2